combination glp 1 and sglt2 GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog GLP-1 & SGLT2 Inhibitor Combination

Description

It blocks clotting factor Xa, slowing clot formation and lowering the chance of stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and clot recurrence after hip or knee replacement

In the subset of patients who had creatinine measurements available, we calculated estimated glomerular filtration rate using the race-free 2021 CKD-EPI (chronic kidney disease epidemiology collaboration) equation.32 Statistical analysis To adjust for confounding, we used 1:1 propensity score matching with the nearest neighbor method and a caliper of 0.01 of the propensity score.33 We used multivariable logistic regression models to estimate the propensity scores

Indeed, a recent systematic review found that GLP-1 RA use was consistently associated with improvements in headache frequency, weight reduction, and reduced need for acetazolamide or surgical interventions

Additionally, mechanistic studies should further clarify how androgen status may modify body composition responses during GLP-1 receptor agonist-associated weight loss, without presuming a direct interaction between GLP-1 signaling and androgen pathways